Compare · head to head
Pliant Therapeutics vs RadNet
Pliant Therapeutics ranks higher overall — 360 rank 41 vs 14.
Pliant Therapeutics leads on Value (48 vs 35), Quality (40 vs 28) and Safety (46 vs 21). RadNet leads on Sentiment (65 vs 55).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Health Care Providers & Services |
| Size | Small | Large |
| ISIN | US7291391057 | US7504911022 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 41 | 14 |
| Value | 48 | 35 |
| Quality | 40 | 28 |
| Growth | NR | 56 |
| Safety | 46 | 21 |
| Sentiment | 55 | 65 |
| Quality details | ||
| Profitability | 30 | 29 |
| Cash Truth | NR | 28 |
Pliant Therapeutics vs Rapport TherapeuticsPliant Therapeutics vs EyePointPliant Therapeutics vs AnaptysBioPliant Therapeutics vs NektarAdd a third stock →
Full analyses: Pliant Therapeutics · RadNet
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100